BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Oncogene

• Publication date

  1996-12-05

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8957093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth retardation and tumour inhibition by BRCA1

  1996cited by this paper
• Location of BRCA1 in Human Breast and Ovarian Cancer Cells

  1996cited by this paper
• BRCA1 is secreted and exhibits properties of a granin

  1996cited by this paper
• Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice.

  1995cited by this paper
• Hormone-dependent regulation of BRCA1 in human breast cancer cells.

  1995cited by this paper
• Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin‐like growth factor‐I in human mammary epithelial cells

  1995cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• Aberrant Subcellular Localization of BRCA1 in Breast Cancer

  1995cited by this paper
• Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.

  1995cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

  1994cited by this paper
• Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

  1994cited by this paper
• D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.

  1992cited by this paper
• Secretion of an epidermal growth factor-like growth factor by epidermal growth factor-independent rat mammary carcinoma cells.

  1991cited by this paper

• BRCA1 knock-down causes telomere dysfunction in mammary epithelial cells

  2009cites this paper
• BRCA1--a good predictive marker of drug sensitivity in breast cancer treatment?

  2006cites this paper
• Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue.

  2005cites this paper
• Induction of Phosphorylation on BRCAI during the Cell Cycle and after DNA Damage

  2005cites this paper
• Extracellular Matrix Enhances Heregulin-Dependent BRCA1 Phosphorylation and Suppresses BRCA1 Expression through Its C Terminus

  2003influential citation
• A nuclear function for the tumor suppressor BRCA1.

  2000cites this paper
• Expression of BRCA1 and BRCA2 in Normal and Neoplastic Cells

  1998cites this paper
• BRCA1: a review of structure and putative functions.

  1998cites this paper
• BRCA1 and BRCA2 proteins: roles in health and disease.

  1998cites this paper
• Estrogen upregulation of BRCA1 expression with no effect on localization

  1998cites this paper
• BRCA1 is associated with the centrosome during mitosis.

  1998cites this paper
• Immunohistochemical analysis of BRCA1 expression in normal human buccal cells.

  1998cites this paper
• Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage.

  1997cites this paper
• Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

  1997cites this paper
• BRCA1 is a cell cycle-regulated nuclear phosphoprotein.

  1997cites this paper